Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 41.30%1.43B | 17.96%818.81M | 71.48%958.28M | -50.85%1.26B | -37.66%1.01B | -67.70%694.13M | -68.50%558.84M | 41.87%2.57B | 18.12%1.63B | 76.45%2.15B |
Transactional financial assets | 101.06%708.01M | 14.02%403.75M | -5.85%353.31M | -23.27%351.14M | -63.94%352.13M | -51.26%354.09M | -62.39%375.27M | -43.70%457.63M | 128.25%976.45M | 45.82%726.45M |
Notes receivable and accounts receivable | -52.19%521.77M | -43.01%893.3M | -7.92%1.15B | -26.02%1.02B | -26.86%1.09B | 0.49%1.57B | -19.33%1.25B | -3.40%1.38B | 9.89%1.49B | 1.86%1.56B |
-Accounts receivable | -52.19%521.77M | -43.01%893.3M | -7.92%1.15B | -26.02%1.02B | -26.86%1.09B | 0.49%1.57B | -19.33%1.25B | -3.40%1.38B | 9.89%1.49B | 1.86%1.56B |
Other receivables (including interest and dividends) | -41.22%114.74M | -25.06%114.03M | -50.63%132.21M | -49.04%151.63M | -45.05%195.2M | -7.61%152.16M | -41.15%267.81M | -29.07%297.56M | -24.50%355.25M | -17.89%164.69M |
-Other receivable | ---- | -25.06%114.03M | ---- | -49.04%151.63M | ---- | -7.61%152.16M | ---- | -29.07%297.56M | ---- | --164.69M |
Advance payment | -62.40%78.57M | -25.61%102.84M | -33.02%134.32M | -13.00%122.89M | -6.79%208.96M | -11.84%138.25M | -31.26%200.54M | -9.70%141.25M | 90.17%224.18M | 78.41%156.83M |
Inventories | -11.42%4.41B | -6.21%4.62B | -3.95%4.47B | 21.42%4.8B | 27.98%4.98B | 30.12%4.93B | 65.77%4.65B | 27.83%3.95B | 5.35%3.89B | -1.17%3.79B |
Receivable financing | -2.72%630.42M | 14.34%365.17M | 79.62%197.71M | -47.15%267.8M | 18.71%648.04M | -7.53%319.38M | -69.27%110.07M | 43.37%506.76M | 11.29%545.88M | -46.05%345.39M |
Other current assets | 7.86%195.53M | 71.84%214.92M | 15.76%152.3M | -19.59%146.92M | 20.59%181.29M | 24.34%125.07M | 160.48%131.56M | -13.30%182.72M | -54.28%150.33M | -70.63%100.59M |
Total current assets | -6.66%8.09B | -8.98%7.54B | 0.02%7.55B | -14.38%8.12B | -6.39%8.67B | -7.90%8.28B | -8.91%7.55B | 14.52%9.49B | 12.08%9.26B | 7.65%8.99B |
Non Current assets | ||||||||||
Other equity investment | 3.61%394.36M | 3.61%394.36M | 3.61%394.36M | 14.94%394.36M | 10.93%380.61M | 10.93%380.61M | 10.93%380.61M | 18.07%343.11M | 29.89%343.11M | 29.89%343.11M |
Investment real estate | 331.99%993.19M | 93.24%447.24M | 254.70%226.97M | 254.56%228.44M | 254.43%229.91M | 254.07%231.44M | 289.58%63.99M | 288.70%64.43M | 287.44%64.87M | 287.35%65.37M |
Long-term equity investment | -0.31%1.13B | 1.32%1.13B | 1.10%1.12B | 0.62%1.12B | 2.34%1.13B | 0.93%1.12B | -4.77%1.11B | -4.57%1.11B | -4.83%1.11B | -5.45%1.11B |
Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | -34.56%11.36M | -34.03%12.63M | -31.16%14.57M | -28.18%16.75M |
Fixed assets | ---- | -4.43%4.52B | ---- | -4.77%4.65B | ---- | -5.87%4.73B | ---- | 66.10%4.88B | ---- | --5.02B |
Constru in process | ---- | -8.90%1.13B | ---- | -2.23%1.26B | ---- | 0.62%1.24B | ---- | -58.22%1.29B | ---- | --1.24B |
Intangible assets | -11.98%792.91M | -14.71%809.53M | -14.40%847.69M | -16.23%866.49M | -16.37%900.84M | -11.65%949.17M | -10.21%990.32M | -9.66%1.03B | -5.60%1.08B | -8.30%1.07B |
Development expenditure | 20.98%1.73B | 21.71%1.68B | 24.98%1.57B | 24.21%1.49B | 25.41%1.43B | 23.67%1.38B | 17.86%1.25B | 18.45%1.2B | 17.59%1.14B | 15.37%1.11B |
Goodwill | -57.91%620.04M | -57.91%620.04M | -28.87%1.47B | -28.87%1.47B | -28.87%1.47B | -28.59%1.47B | -59.65%2.07B | -59.65%2.07B | -59.65%2.07B | -58.79%2.06B |
Long deferred expense | 326.77%39.74M | 151.80%23.51M | 39.30%24.35M | -52.01%8.3M | -49.93%9.31M | -20.98%9.34M | 52.97%17.48M | 41.57%17.29M | 37.34%18.6M | -12.37%11.82M |
Deferred tax assets | 2.89%387.55M | 5.74%389.32M | 17.78%358.73M | 28.80%381.18M | 44.89%376.66M | 66.32%368.19M | 48.19%304.58M | 46.53%295.94M | 27.09%259.97M | 0.32%221.38M |
Usufruct assets | -32.67%16.28M | -56.86%12.08M | -38.47%19.72M | -38.31%22.55M | -41.76%24.18M | -32.81%28M | 17.69%32.04M | 19.15%36.55M | 15.95%41.53M | 21.85%41.67M |
Other non current assets | -12.87%619.07M | -9.87%637.34M | -3.70%684.38M | 2.27%712.19M | 8.44%710.47M | 9.60%707.1M | 2.85%710.71M | -5.32%696.36M | -8.25%655.16M | -12.51%645.18M |
Total non current assets | -7.06%11.75B | -6.50%11.79B | -3.61%12.6B | -3.44%12.61B | -2.87%12.64B | -2.69%12.61B | -17.69%13.07B | -17.29%13.06B | -17.06%13.01B | -16.42%12.96B |
Total assets | -6.90%19.84B | -7.48%19.33B | -2.28%20.15B | -8.05%20.73B | -4.33%21.31B | -4.83%20.89B | -14.68%20.62B | -6.34%22.55B | -7.01%22.27B | -7.99%21.95B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 117.43%491.48M | 102.59%486.46M | -38.71%242.88M | -63.31%183.19M | -53.07%226.04M | -62.41%240.12M | -39.89%396.3M | -28.12%499.31M | -32.24%481.61M | -50.68%638.76M |
Notes payable and accounts payable | 1.63%2.63B | 13.98%2.85B | 32.90%2.53B | 5.93%2.57B | 3.38%2.59B | 4.10%2.5B | 2.75%1.9B | 16.26%2.42B | 14.72%2.51B | -3.86%2.4B |
-Notes payable | -80.84%24.9M | -57.93%48.09M | -24.53%120M | -49.15%150M | -43.21%130M | 28.47%114.3M | 44.12%159M | 267.47%295M | 625.37%228.93M | 44.53%88.97M |
-Accounts payable | 5.99%2.61B | 17.43%2.8B | 38.14%2.41B | 13.57%2.42B | 8.07%2.46B | 3.16%2.38B | 0.13%1.74B | 6.20%2.13B | 5.77%2.28B | -5.08%2.31B |
Contract liabilities | 8.70%263.8M | -9.34%215.76M | -23.73%132.13M | -51.22%158.52M | -12.00%242.68M | -36.79%238M | -14.20%173.24M | 17.65%324.99M | 21.30%275.77M | 55.33%376.52M |
Salaries payable | 4.99%133.13M | 9.69%144.66M | 2.40%96.87M | -0.89%123M | -1.21%126.8M | 0.43%131.88M | 8.84%94.6M | 6.44%124.11M | 15.30%128.35M | 13.50%131.31M |
Taxs payable | 26.95%142.61M | -24.27%141.17M | -10.04%154.16M | -28.12%133.29M | -44.69%112.34M | -34.88%186.4M | -49.76%171.36M | -19.87%185.43M | -24.09%203.09M | -18.13%286.25M |
Other payable (including interest and dividends) | -21.31%2.1B | -24.09%2.07B | -14.33%2.11B | -35.66%2.35B | -2.58%2.67B | 0.33%2.73B | -4.64%2.47B | 37.24%3.65B | 15.90%2.74B | 17.72%2.72B |
-Dividend payable | 64.68%67.38M | 64.68%67.38M | 64.68%67.38M | -83.95%176.92M | 0.46%40.91M | 0.46%40.91M | 0.46%40.91M | 176.90%1.1B | --40.73M | --40.73M |
-Other payable | ---- | -25.44%2.01B | ---- | -14.73%2.17B | ---- | 0.33%2.69B | ---- | 12.61%2.54B | ---- | --2.68B |
Non current liabilities due within one year | 45.27%1.32B | 45.72%1.17B | 57.06%794.22M | 48.18%811.73M | 75.42%905.23M | 122.40%802.26M | -21.72%505.67M | -27.48%547.79M | 44.80%516.04M | 11.90%360.73M |
Other current liabilities | 18.00%32.99M | -12.27%26.93M | -24.64%16.67M | -52.66%19.77M | -20.66%27.96M | -36.44%30.7M | -14.72%22.12M | 18.29%41.77M | 5.55%35.24M | 56.48%48.29M |
Total current liabilities | 3.06%7.11B | 3.59%7.1B | 6.04%6.08B | -18.61%6.34B | 0.22%6.9B | -1.51%6.86B | -10.42%5.73B | 13.75%7.79B | 10.09%6.89B | -2.81%6.96B |
Current liabilities | ||||||||||
Long term loan | -15.72%2.15B | -5.34%1.99B | 23.71%2.78B | 29.20%2.87B | 27.03%2.55B | -1.38%2.1B | 11.26%2.25B | 15.14%2.22B | -15.14%2.01B | 11.81%2.13B |
Long term account payable | ---- | -49.65%72M | ---- | --120.81M | ---- | -0.69%143M | ---- | ---- | ---- | --144M |
Estimate liabilities | -40.40%3.02M | -40.40%3.02M | --963.64K | --2.07M | --5.07M | --5.07M | ---- | ---- | ---- | ---- |
Deferred tax liabilities | -13.35%74.68M | -21.30%71.24M | -13.57%79.16M | -13.96%84.32M | -17.35%86.19M | 3.44%90.52M | 1.75%91.59M | 3.09%98.01M | 3.42%104.28M | -17.61%87.51M |
Long term deferred income | -13.11%267.49M | -9.19%283.59M | -4.71%290.73M | -4.40%299.85M | -4.59%307.83M | -5.53%312.29M | -9.84%305.11M | -9.34%313.67M | -7.34%322.65M | -4.36%330.55M |
Lease liabilities | -17.55%7.06M | -77.36%2.62M | -79.54%3.59M | -68.44%6.77M | -62.72%8.56M | -56.07%11.58M | -4.65%17.56M | 8.10%21.45M | 11.52%22.96M | 37.76%26.37M |
Total non current liabilities | -13.35%2.67B | -9.10%2.42B | 15.68%3.27B | 19.98%3.39B | 16.64%3.09B | -2.04%2.66B | 10.71%2.82B | 18.00%2.82B | -6.64%2.65B | 14.42%2.72B |
Total liabilities | -2.01%9.79B | 0.04%9.52B | 9.22%9.35B | -8.35%9.73B | 4.78%9.99B | -1.66%9.52B | -4.40%8.56B | 14.85%10.61B | 4.87%9.53B | 1.48%9.68B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%1.11B | 0.00%1.11B | 0.00%1.11B | 0.00%1.11B | 0.00%1.11B | 0.00%1.11B | 0.00%1.11B | -3.11%1.11B | -3.11%1.11B | -3.11%1.11B |
Capital reserve funds | 0.00%2.49B | 0.00%2.49B | -0.03%2.49B | -0.03%2.49B | -0.03%2.49B | -0.03%2.49B | 0.00%2.49B | -26.48%2.49B | -26.48%2.49B | -26.48%2.49B |
Surplus reserve funds | 0.00%570.79M | 0.00%570.79M | 0.00%570.79M | 0.00%570.79M | 0.00%570.79M | 0.00%570.79M | 0.00%570.79M | 0.00%570.79M | 0.00%570.79M | 0.00%570.79M |
Retained profit | -6.57%7.05B | -9.27%6.75B | -5.33%7.61B | -4.22%7.53B | -12.55%7.55B | -9.08%7.44B | -27.56%8.04B | -26.19%7.86B | -19.03%8.64B | -19.07%8.18B |
Less:Treasury stock | 351.48%760.13M | 38,436.49%712.38M | --634.92M | --425.44M | --168.37M | --1.85M | ---- | ---- | ---- | ---- |
Other composite income | -11.50%10.29M | -5.12%11.23M | 1.45%11.77M | -0.47%11.49M | 18.59%11.63M | -2.46%11.84M | 15.47%11.6M | 1.45%11.54M | -43.50%9.81M | -37.12%12.13M |
Attributable parent company shareholders equity adjustment items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- |
Shareholders equity without minority interests | -9.42%10.48B | -12.06%10.22B | -8.71%11.16B | -6.29%11.29B | -9.76%11.56B | -6.03%11.62B | -20.01%12.23B | -18.81%12.05B | -13.72%12.82B | -13.53%12.36B |
Minority interests | -73.38%-424.09M | -69.46%-408.38M | -119.18%-357.71M | -147.63%-284.49M | -224.69%-244.61M | -175.17%-240.98M | -136.62%-163.2M | -1,569.82%-114.89M | -970.69%-75.34M | -447.99%-87.58M |
Other items effecting shareholder equity | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- |
Total shareholder equity | -11.21%10.05B | -13.78%9.81B | -10.44%10.8B | -7.77%11B | -11.15%11.32B | -7.32%11.38B | -20.72%12.06B | -19.55%11.93B | -14.27%12.74B | -14.30%12.28B |
Adjustment items of liabilities and equity | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- |
Total liabilityies and equity | -6.90%19.84B | -7.48%19.33B | -2.28%20.15B | -8.05%20.73B | -4.33%21.31B | -4.83%20.89B | -14.68%20.62B | -6.34%22.55B | -7.01%22.27B | -7.99%21.95B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.